Materiały źródłowe

• #1 Tay-Sachs disease | Altru Health System

  https://www.altru.org/health-library/conditions/tay-sachs-disease

  Tay-Sachs disease is a genetic disorder that is passed from parents to their children. It occurs when a child inherits a flaw (mutation) in the HEXA gene from both parents. […] The genetic change that causes Tay-Sachs disease results in a deficiency of the enzyme beta-hexosaminidase A. This enzyme is required to break down the fatty substance GM2 ganglioside. The buildup of fatty substances damages nerve cells in the brain and spinal cord. Severity and age of onset of the disease relates to how much enzyme is still produced.

• #2 Tay-Sachs Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564432/

  Tay-Sachs disease belongs to a group of autosomal recessively inherited lysosomal storage disorders called GM2 gangliosidoses. GM2 gangliosides accumulate inside lysosomes, primarily affecting the nervous system and resulting in neuronal dysfunction and neurodegeneration. The other GM2 gangliosidoses are Sandhoff disease and the AB variant. […] Tay-Sachs disease is an autosomal recessive disorder caused by a mutation in HEXA, which encodes the enzymes beta-hexosaminidase A. HEXA is located at 15q23. More than 130 mutations have been identified, including single gene deletions, substitution, insertion splicing alteration, duplication, and complex gene rearrangements. Very rare founder variants of Tay-Sachs disease have been identified recently in India.

• #3 Tay-Sachs disease: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/tay-sachs-disease/

  Tay-Sachs disease is a rare, inherited disorder that is characterized by neurological problems caused by the death of nerve cells (neurons) in the brain and spinal cord (central nervous system). […] Variants in the HEXA gene cause Tay-Sachs disease. The HEXA gene provides instructions for making one part (the alpha subunit) of an enzyme called beta-hexosaminidase A. […] HEXA gene variants affect the ability of the beta-hexosaminidase A enzyme to break down GM2 ganglioside. As a result, GM2 ganglioside accumulates to toxic levels, particularly in neurons in the central nervous system. Damage caused by the buildup of GM2 ganglioside leads to the dysfunction and eventual death of these neurons, which causes the signs and symptoms of Tay-Sachs disease. […] HEXA gene variants that eliminate or severely reduce beta-hexosaminidase A enzyme function likely lead to the infantile form of Tay-Sachs disease, and variants that allow some residual enzyme activity tend to cause the juvenile or late-onset form of the condition. […] Because Tay-Sachs disease impairs the function of a lysosomal enzyme and involves the buildup of GM2 ganglioside, this condition is sometimes referred to as a lysosomal storage disorder or a GM2-gangliosidosis.

• #4 Tay-Sachs Disease and Sandhoff Disease – Pediatrics – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/pediatrics/inherited-disorders-of-metabolism/tay-sachs-disease-and-sandhoff-disease

  Tay-Sachs disease and Sandhoff disease are sphingolipidoses, inherited disorders of metabolism, caused by hexosaminidase deficiency that causes severe neurologic symptoms and early death. […] Deficiency of hexosaminidase A results in accumulation of GM2 in the brain. Inheritance is autosomal recessive; the most common mutations are carried by 1/27 unaffected adults of Eastern European (Ashkenazi) Jewish origin, although other mutations cluster in some French-Canadian and Cajun populations. […] The disease develops in 25% of the children when both parents are carriers.

• #5 Tay-Sachs disease – Genes and Disease – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK22250/

  Tay-Sachs is an autosomal recessive disease caused by mutations in both alleles of a gene (HEXA) on chromosome 15. HEXA codes for the alpha subunit of the enzyme -hexosaminidase A. This enzyme is found in lysosomes, organelles that break down large molecules for recycling by the cell. Normally, -hexosaminidase A helps to degrade a lipid called GM2 ganglioside, but in Tay-Sachs individuals, the enzyme is absent or present only in very reduced amounts, allowing excessive accumulation of the GM2 ganglioside in neurons. […] The progressive neurodegeneration seen in the varied forms of Tay-Sachs depends upon the speed and degree of GM2 ganglioside accumulation, which in turn is dependent upon the level of functional -hexosaminidase A present in the body.

• #6 Tay-Sachs Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/14348-tay-sachs-disease

  Tay-Sachs disease is a genetic condition that causes damage and, ultimately, the death of nerve cells (neurons) in your child’s brain and spinal cord. […] A genetic change (mutation) of the HEXA gene causes Tay-Sachs disease. […] The HEXA gene gives your cells instructions to make an enzyme (hexosaminidase A) that breaks down toxic substances in your body. If this enzyme isn’t available to do its job, a fatty substance collects in your cells. This damages and, ultimately, destroys cells within your brain and spinal cord, leading to symptoms of Tay-Sachs disease. […] Tay-Sachs disease is autosomal recessive. This means that two copies of the disease-causing genetic variant (change or mutation) to the HEXA gene need to be present for a Tay-Sachs disease diagnosis. […] Tay-Sachs disease happens when both parents have a mutated HEXA gene and pass it on to their children. As a result, neither copy of the baby’s HEXA gene works.

• #7 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #8 Tay-Sachs Disease

  https://lakecountyin.gov/departments/health/nursing-clinic/diseases-and-conditions/genetic-disorders/tay-sachs-disease

  Tay-Sachs Disease is caused by a deficiency of an enzyme called hexosaminidase A (Hex-A). This enzyme is crucial for the breakdown of a fatty substance known as GM2 ganglioside in nerve cells. Without sufficient Hex-A activity, GM2 ganglioside accumulates to toxic levels, causing progressive damage to nerve cells. […] Tay-Sachs Disease is caused by mutations in the HEXA gene located on chromosome 15. These mutations lead to a deficiency or absence of the Hex-A enzyme. […] Tay-Sachs Disease is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated HEXA gene (one from each parent) to develop the disease. Carriers of the mutation typically do not exhibit symptoms but can pass the mutated gene to their offspring.

• #9 Tay-Sachs disease: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/001417.htm

  Tay-Sachs disease occurs when the body lacks hexosaminidase A. This is a protein that helps break down a group of chemicals found in nerve tissue called gangliosides. Without this protein, gangliosides, particularly ganglioside GM2, build up in cells, often nerve cells in the brain. […] Tay-Sachs disease is caused by a variant gene on chromosome 15. When both parents carry the variant Tay-Sachs gene, a child has a 25% chance of developing the disease. The child must receive two copies of the variant gene, one from each parent, in order to become sick. If only one parent passes the variant gene to the child, the child is called a carrier. They will not be sick, but may pass the disease to their own children. […] Anyone can be a carrier of the Tay-Sachs gene. But, the disease is most common among people with Ashkenazi Jewish ancestry, where 1 in every 27 people carries the Tay-Sachs gene.

• #10 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  TaySachs disease is caused by a genetic mutation in the HEXA gene on chromosome 15, which codes a subunit of the hexosaminidase enzyme known as hexosaminidase A. […] It is inherited in an autosomal recessive manner. […] The mutation disrupts the activity of the enzyme, which results in the build-up of the molecule GM2 ganglioside within cells, leading to toxicity. […] TaySachs disease is an autosomal recessive genetic disorder, meaning that when both parents are carriers, there is a 25% risk of giving birth to an affected child with each pregnancy. […] TaySachs results from mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of beta-N-acetylhexosaminidase A, a lysosomal enzyme. […] Classic infantile TaySachs disease results when a child has inherited mutations from both parents that completely stop the biodegradation of gangliosides.

• #11 Tay-Sachs disease: Causes, symptoms, diagnosis, and more

  https://www.medicalnewstoday.com/articles/tay-sachs-disease

  Tay-Sachs disease is an inherited, life threatening condition where nerve cells in the brain and spinal cord degenerate and die. This leads to progressive neurological dysfunction. […] A deficiency in the enzyme that breaks down a fatty substance in nerve cells, HexA, may cause Tay-Sachs disease. This deficiency stems from inheriting a mutated form of the gene coding for the specific enzyme that a person inherits from each parent. […] A deficiency of the enzyme beta-hexosaminidase (HexA) causes Tay-Sachs disease. […] When insufficient HexA is available, GM2 ganglioside builds up atypically in cells in the brain and spinal cord. This leads to cell degeneration and death. […] The condition stems from a gene mutation on chromosome 15 that codes for HexA production. […] People inherit this condition in an autosomal recessive pattern. […] The condition results from a deficiency in HexA, an enzyme that prevents the accumulation of a fatty substance in the nerve cells. This happens when someone inherits a pair of mutated genes that code for the bodys HexA synthesis.

• #12 GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease | Journal of Neuroinflammation | Full Text

  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01947-6

  Tay-Sachs disease (TSD), a type of GM2-gangliosidosis, is a progressive neurodegenerative lysosomal storage disorder caused by mutations in the subunit of the lysosomal -hexosaminidase enzyme. This disease is characterized by excessive accumulation of GM2 ganglioside, predominantly in the central nervous system. […] TSD is caused by mutations in the Hexa gene, which encodes the subunit of lysosomal -hexosaminidase (HEXA), an enzyme that converts GM2 to GM3 ganglioside. […] It has been shown that abnormal accumulation of GM2 ganglioside in neurons leads to cytoplasmic vacuolation and progressive neurodegeneration, resulting in neuronal death, Purkinje cell depletion, and astrogliosis. […] A previous study showed that storage of GM1 and GM2 gangliosides in the CNS led to microgliosis and astrogliosis, and that the degree of inflammation is correlated with increased levels of ganglioside accumulation.

• #13 Tay-Sachs Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564432/

  Tay-Sachs disease belongs to a group of autosomal recessively inherited lysosomal storage disorders called GM2 gangliosidoses. GM2 gangliosides accumulate inside lysosomes, primarily affecting the nervous system and resulting in neuronal dysfunction and neurodegeneration. The other GM2 gangliosidoses are Sandhoff disease and the AB variant. […] Tay-Sachs disease is an autosomal recessive disorder caused by a mutation in HEXA, which encodes the enzymes beta-hexosaminidase A. HEXA is located at 15q23. More than 130 mutations have been identified, including single gene deletions, substitution, insertion splicing alteration, duplication, and complex gene rearrangements. Very rare founder variants of Tay-Sachs disease have been identified recently in India.

• #14 Tay-Sachs Disease – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/tay-sachs-disease/

  TSD is a genetic disease caused by a change in the HEXA gene. The change causes a lack of an enzyme called beta-hexosaminidase A. This enzyme is normally present inside the nerve cells of the brain. It helps to break down and recycle molecules called gangliosides. When this enzyme is lacking, the gangliosides build up and cause damage to brain cells. […] TSD happens because of an abnormal change (a mutation) in a gene called HEXA. There are at least 130 mutations of HEXA that have been identified. All of these mutations cause a deficiency of an enzyme called beta-hexosaminidase A. This enzyme is normally present inside the nerve cells of the brain. It helps to break down and recycle molecules called gangliosides. When this enzyme is missing, the gangliosides build up and cause damage to the brain cells.

• #15 Tay-Sachs Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564432/

  Tay-Sachs disease belongs to a group of autosomal recessively inherited lysosomal storage disorders called GM2 gangliosidoses. GM2 gangliosides accumulate inside lysosomes, primarily affecting the nervous system and resulting in neuronal dysfunction and neurodegeneration. The other GM2 gangliosidoses are Sandhoff disease and the AB variant. […] Tay-Sachs disease is an autosomal recessive disorder caused by a mutation in HEXA, which encodes the enzymes beta-hexosaminidase A. HEXA is located at 15q23. More than 130 mutations have been identified, including single gene deletions, substitution, insertion splicing alteration, duplication, and complex gene rearrangements. Very rare founder variants of Tay-Sachs disease have been identified recently in India.

• #16 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  Late-onset forms occur due to the diverse mutation base people with TaySachs disease may technically be heterozygotes, with two differing HEXA mutations that both inactivate, alter, or inhibit enzyme activity. […] Most TaySachs mutations probably do not directly affect protein functional elements (e.g., the active site). Instead, they cause incorrect folding (disrupting function) or disable intracellular transport.

• #17

  https://www.omim.org/entry/272800

  A number sign (#) is used with this entry because Tay-Sachs disease (TSD) is caused by homozygous or compound heterozygous mutation in the alpha subunit of the hexosaminidase A gene (HEXA; 606869) on chromosome 15q23. […] Tay-Sachs disease is an autosomal recessive, progressive neurodegenerative disorder which, in the classic infantile form, is usually fatal by age 2 or 3 years. […] The gene responsible for the juvenile form has been shown by molecular analysis of the HEXA gene to be allelic to that responsible for the classic infantile form of Tay-Sachs disease (Paw et al., 1990). […] Myerowitz and Costigan (1988) demonstrated that the most frequent DNA lesion in Tay-Sachs disease in Ashkenazi Jews is a 4-bp insertion in exon 11 of the HEXA gene (606869.0001). […] The defect is a partial deficiency of hexosaminidase A. […] The relatively high frequency of the atypical adult disorder(s) in Ashkenazim is the result of the high frequency of the TSD allele to create genetic compounds.

• #18 Tay-Sachs Disease | The Children’s Hospital at Montefiore

  https://www.cham.org/health-library/article?id=hw182975

  Tay-Sachs can occur when parents pass on a changed gene to their child. […] The juvenile and late-onset forms of Tay-Sachs are also caused by a changed gene from both parents. […] The changed gene that causes Tay-Sachs disease is more commonly found in people of Ashkenazi Jewish descent. About 3 out of 100 people in this population are carriers of the disease. People of French-Canadian descent or Cajun descent are also more likely to carry the changed gene. […] Carriers of the Tay-Sachs gene changes can pass the changed gene to their children even though the carriers don’t have the disease. If both you and your partner are carriers, there is a 1-out-of-4 chance (25%) that any child you have will have Tay-Sachs disease.

• #19 Tay-Sachs Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564432/

  Tay-Sachs disease belongs to a group of autosomal recessively inherited lysosomal storage disorders called GM2 gangliosidoses. GM2 gangliosides accumulate inside lysosomes, primarily affecting the nervous system and resulting in neuronal dysfunction and neurodegeneration. The other GM2 gangliosidoses are Sandhoff disease and the AB variant. […] Tay-Sachs disease is an autosomal recessive disorder caused by a mutation in HEXA, which encodes the enzymes beta-hexosaminidase A. HEXA is located at 15q23. More than 130 mutations have been identified, including single gene deletions, substitution, insertion splicing alteration, duplication, and complex gene rearrangements. Very rare founder variants of Tay-Sachs disease have been identified recently in India.

• #20 Tay-Sachs disease | Altru Health System

  https://www.altru.org/health-library/conditions/tay-sachs-disease

  Tay-Sachs disease is a genetic disorder that is passed from parents to their children. It occurs when a child inherits a flaw (mutation) in the HEXA gene from both parents. […] The genetic change that causes Tay-Sachs disease results in a deficiency of the enzyme beta-hexosaminidase A. This enzyme is required to break down the fatty substance GM2 ganglioside. The buildup of fatty substances damages nerve cells in the brain and spinal cord. Severity and age of onset of the disease relates to how much enzyme is still produced.

• #21 Tay-Sachs disease: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/tay-sachs-disease/

  Tay-Sachs disease is a rare, inherited disorder that is characterized by neurological problems caused by the death of nerve cells (neurons) in the brain and spinal cord (central nervous system). […] Variants in the HEXA gene cause Tay-Sachs disease. The HEXA gene provides instructions for making one part (the alpha subunit) of an enzyme called beta-hexosaminidase A. […] HEXA gene variants affect the ability of the beta-hexosaminidase A enzyme to break down GM2 ganglioside. As a result, GM2 ganglioside accumulates to toxic levels, particularly in neurons in the central nervous system. Damage caused by the buildup of GM2 ganglioside leads to the dysfunction and eventual death of these neurons, which causes the signs and symptoms of Tay-Sachs disease. […] HEXA gene variants that eliminate or severely reduce beta-hexosaminidase A enzyme function likely lead to the infantile form of Tay-Sachs disease, and variants that allow some residual enzyme activity tend to cause the juvenile or late-onset form of the condition. […] Because Tay-Sachs disease impairs the function of a lysosomal enzyme and involves the buildup of GM2 ganglioside, this condition is sometimes referred to as a lysosomal storage disorder or a GM2-gangliosidosis.

• #22 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #23 GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease | Journal of Neuroinflammation | Full Text

  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01947-6

  Here, we demonstrated that an accumulation of GM2 ganglioside led to the activation of the microglial/macrophage system in the brain and retina of Hexa/Neu3 mice, compared with that in age-matched WT, Hexa-/-, and Neu3-/- mice. Activation of this cellular system led to an altered expression profile of both pro- and anti-inflammatory cytokines, as well as chemokines, in the cortex and cerebellum. […] Our data suggest that abnormal GM2 ganglioside accumulation in the CNS of early onset Tay-Sachs disease mouse model activates neuroinflammation, by triggering the release of pro-inflammatory cytokines and chemokines, microgliosis, astrogliosis, and the infiltration of PBMC in the CNS.

• #24 GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease | Journal of Neuroinflammation | Full Text

  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01947-6

  Here, we demonstrated that an accumulation of GM2 ganglioside led to the activation of the microglial/macrophage system in the brain and retina of Hexa/Neu3 mice, compared with that in age-matched WT, Hexa-/-, and Neu3-/- mice. Activation of this cellular system led to an altered expression profile of both pro- and anti-inflammatory cytokines, as well as chemokines, in the cortex and cerebellum. […] Our data suggest that abnormal GM2 ganglioside accumulation in the CNS of early onset Tay-Sachs disease mouse model activates neuroinflammation, by triggering the release of pro-inflammatory cytokines and chemokines, microgliosis, astrogliosis, and the infiltration of PBMC in the CNS.

• #25 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  TaySachs disease is caused by a genetic mutation in the HEXA gene on chromosome 15, which codes a subunit of the hexosaminidase enzyme known as hexosaminidase A. […] It is inherited in an autosomal recessive manner. […] The mutation disrupts the activity of the enzyme, which results in the build-up of the molecule GM2 ganglioside within cells, leading to toxicity. […] TaySachs disease is an autosomal recessive genetic disorder, meaning that when both parents are carriers, there is a 25% risk of giving birth to an affected child with each pregnancy. […] TaySachs results from mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of beta-N-acetylhexosaminidase A, a lysosomal enzyme. […] Classic infantile TaySachs disease results when a child has inherited mutations from both parents that completely stop the biodegradation of gangliosides.

• #26 Tay-Sachs disease | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/tay-sachs-disease

  Tay-Sachs disease (TSD) is a genetic condition that affects the nervous system. […] TSD is caused by an alteration in the HEXA gene on chromosome 15. […] In children with TSD, the gene that tells the neurones to produce HexA is altered and stops the neurones from producing the enzyme. […] Tay-Sachs disease is most commonly observed in individuals of Jewish and French-Canadian descent, but can also occur in people from other backgrounds. […] TSD follows an autosomal recessive inheritance pattern. […] To develop TSD, a child must inherit an altered gene copy from both parents. […] If a male and a female, each carrying an altered HEXA gene, conceive a child, there is a one-in-four chance that the child will have TSD. […] If only one parent has the altered gene, none of their children will develop the condition, but each child has a 50 per cent chance of being a genetic carrier of TSD.

• #27 Tay-Sachs disease – symptoms, causes, diagnosis & treatment | healthdirect

  https://www.healthdirect.gov.au/tay-sachs-disease

  Tay-Sachs disease is a genetic disorder caused by a deficiency in an enzyme that is needed for the brain to function properly. […] Tay-Sachs disease is caused by a problem with the HEXA gene. This leads to a deficiency in an enzyme that is needed for the brain to function properly. […] Tay-Sachs disease is an autosomal recessive disorder. This means that a child must inherit faulty HEXA genes from both parents in order to have Tay-Sachs disease. […] If both parents are carriers of faulty HEXA genes, there is a 1 in 4 chance that the child will inherit Tay-Sachs disease.

• #28 Tay-Sachs Disease: Symptoms, Causes, Treatment

  https://resources.healthgrades.com/right-care/brain-and-nerves/tay-sachs-disease

  Tay-Sachs disease is a rare, inherited disorder. It is a neurodegenerative disease that results in a fatal loss of nerve cells. […] The genetic mutations cause a deficiency in the enzyme hexosaminidase A (HEXA). This deficiency allows a substance, GM2 ganglioside, to build up in nerve cells in the brain and spinal cord. […] Tay-Sachs disease is the result of mutations in the HEXA gene. This gene helps code for the production of an enzyme, also called HEXA. With a mutated gene, the body does not make enough functional enzymes. Without enough HEXA, the body cannot break down GM2. Instead, it accumulates in nerve cells of the brain and spinal cord. This buildup is toxic to the nerve cells. […] People inherit the mutations of Tay-Sachs disease. Research has identified more than 80 different mutations. The inheritance pattern is autosomal recessive. This means a person must have two mutated copies of the gene to have the disease.

• #29 Tay-Sachs disease

  https://www.nhs.uk/conditions/tay-sachs-disease/

  Tay-Sachs disease is caused by a problem in a child’s genes that means their nerves stop working properly. […] A child can only have it if both parents have this faulty gene. The parents themselves don’t usually have any symptoms this is known as being a „carrier”. […] If 2 people who are carriers have a child, there’s a: 1 in 4 (25%) chance the child won’t inherit any faulty genes and won’t have Tay-Sachs disease or be able to pass it on, 1 in 2 (50%) chance the child inherits a faulty gene from one parent and becomes a carrier, but won’t have the condition themselves, 1 in 4 (25%) chance the child inherits a faulty gene from both parents and develops Tay-Sachs disease.

• #30 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #31 Tay-Sachs disease

  https://www.nhs.uk/conditions/tay-sachs-disease/

  Tay-Sachs disease is caused by a problem in a child’s genes that means their nerves stop working properly. […] A child can only have it if both parents have this faulty gene. The parents themselves don’t usually have any symptoms this is known as being a „carrier”. […] If 2 people who are carriers have a child, there’s a: 1 in 4 (25%) chance the child won’t inherit any faulty genes and won’t have Tay-Sachs disease or be able to pass it on, 1 in 2 (50%) chance the child inherits a faulty gene from one parent and becomes a carrier, but won’t have the condition themselves, 1 in 4 (25%) chance the child inherits a faulty gene from both parents and develops Tay-Sachs disease.

• #32 How Common Is Tay-Sachs Disease?

  https://www.healthline.com/health/how-common-is-tay-sach-disease

  Tay-Sachs disease is an inherited metabolic disorder that affects the central nervous system. Symptoms of the disease typically begin in early childhood, around the age of 6 months. […] Tay-Sachs is a genetic disease that is inherited in an autosomal recessive manner. This means that a child must inherit two affected hexosaminidase-A genes one from each parent in order to develop the disease. […] In fact, the main risk factor for developing the disease is having biological parents who are both carriers. If two carriers have a child, there is a 1 in 4 chance the child will develop the disease and a 2 in 4 chance the child will be a carrier. […] If both biological parents are carriers of the affected gene, there’s a 25% chance their child will develop Tay-Sachs. There’s a 50% chance their child will be a carrier and a 25% chance their child will be unaffected.

• #33 Tay-Sachs Disease – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/tay-sachs-disease/

  TSD is an inherited genetic disease. People with TSD have parents who carry the genetic mutation but are not affected by it. TSD is inherited as an autosomal recessive condition. This means that one abnormal copy of the gene comes from each parent. If two parents who are carriers have a child: There is a 1 in 4 chance the child will have TSD. There is a 2 in 4 chance the child will become a carrier, but not develop TSD. There is a 1 in 4 chance the child will not be a carrier or have the disease. […] The risk of having the TSD is the same in males and females. However, some people are at higher risk of being carriers or having the disease. For example, in the Ashkenazi Jewish population, around 1 in 30 people are carriers of a HEXA mutation. TSD occurs in around 1 in 3500 births.

• #34 Tay-Sachs disease

  https://www.nhs.uk/conditions/tay-sachs-disease/

  Tay-Sachs disease is caused by a problem in a child’s genes that means their nerves stop working properly. […] A child can only have it if both parents have this faulty gene. The parents themselves don’t usually have any symptoms this is known as being a „carrier”. […] If 2 people who are carriers have a child, there’s a: 1 in 4 (25%) chance the child won’t inherit any faulty genes and won’t have Tay-Sachs disease or be able to pass it on, 1 in 2 (50%) chance the child inherits a faulty gene from one parent and becomes a carrier, but won’t have the condition themselves, 1 in 4 (25%) chance the child inherits a faulty gene from both parents and develops Tay-Sachs disease.

• #35 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #36 Tay-Sachs Disease (for Parents) | Nemours KidsHealth

  https://kidshealth.org/en/parents/tay-sachs.html

  A baby with Tay-Sachs disease is born without an important enzyme. Enzymes are proteins that control chemical reactions in the body. Without this enzyme, called hexosaminidase A (HEXA), fatty proteins build up in the brain and lead to damage in the brain and spinal cord. […] Tay-Sachs disease is a condition that runs in families. A child gets it by inheriting the gene for it from both parents. The parents are carriers of the gene. This means that they each have one of the genes for Tay-Sachs disease. Carriers of Tay-Sachs disease do not show any symptoms of it.

• #37 Tay-Sachs disease: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/001417.htm

  Tay-Sachs disease occurs when the body lacks hexosaminidase A. This is a protein that helps break down a group of chemicals found in nerve tissue called gangliosides. Without this protein, gangliosides, particularly ganglioside GM2, build up in cells, often nerve cells in the brain. […] Tay-Sachs disease is caused by a variant gene on chromosome 15. When both parents carry the variant Tay-Sachs gene, a child has a 25% chance of developing the disease. The child must receive two copies of the variant gene, one from each parent, in order to become sick. If only one parent passes the variant gene to the child, the child is called a carrier. They will not be sick, but may pass the disease to their own children. […] Anyone can be a carrier of the Tay-Sachs gene. But, the disease is most common among people with Ashkenazi Jewish ancestry, where 1 in every 27 people carries the Tay-Sachs gene.

• #38 Tay-Sachs Disease – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/tay-sachs-disease/

  TSD is an inherited genetic disease. People with TSD have parents who carry the genetic mutation but are not affected by it. TSD is inherited as an autosomal recessive condition. This means that one abnormal copy of the gene comes from each parent. If two parents who are carriers have a child: There is a 1 in 4 chance the child will have TSD. There is a 2 in 4 chance the child will become a carrier, but not develop TSD. There is a 1 in 4 chance the child will not be a carrier or have the disease. […] The risk of having the TSD is the same in males and females. However, some people are at higher risk of being carriers or having the disease. For example, in the Ashkenazi Jewish population, around 1 in 30 people are carriers of a HEXA mutation. TSD occurs in around 1 in 3500 births.

• #39 Tay-Sachs Disease

  https://www.myactivehealth.com/hwcontent/content/special/hw182975.html

  Tay-Sachs can occur when parents pass on a changed gene to their child. […] If a baby gets the changed gene from both parents, he or she will get the disease. […] The changed gene that causes Tay-Sachs disease is more commonly found in people of Ashkenazi Jewish descent. About 1 out of 30 people in this population is a carrier of the disease. […] In late-onset Tay-Sachs (LOTS), the body makes a small amount of hex A. People with LOTS inherit the late-onset hex A gene change from one or both parents. […] Carriers of the Tay-Sachs gene changes can pass the changed gene to their children even though the carriers don’t have the disease. If both you and your partner are carriers, there is a 1-out-of-4 chance (25%) that any child you have will have Tay-Sachs disease.

• #40 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  Late-onset forms occur due to the diverse mutation base people with TaySachs disease may technically be heterozygotes, with two differing HEXA mutations that both inactivate, alter, or inhibit enzyme activity. […] Most TaySachs mutations probably do not directly affect protein functional elements (e.g., the active site). Instead, they cause incorrect folding (disrupting function) or disable intracellular transport.

• #41 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  TaySachs disease is caused by a genetic mutation in the HEXA gene on chromosome 15, which codes a subunit of the hexosaminidase enzyme known as hexosaminidase A. […] It is inherited in an autosomal recessive manner. […] The mutation disrupts the activity of the enzyme, which results in the build-up of the molecule GM2 ganglioside within cells, leading to toxicity. […] TaySachs disease is an autosomal recessive genetic disorder, meaning that when both parents are carriers, there is a 25% risk of giving birth to an affected child with each pregnancy. […] TaySachs results from mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of beta-N-acetylhexosaminidase A, a lysosomal enzyme. […] Classic infantile TaySachs disease results when a child has inherited mutations from both parents that completely stop the biodegradation of gangliosides.

• #42

  https://www.omim.org/entry/272800

  A number sign (#) is used with this entry because Tay-Sachs disease (TSD) is caused by homozygous or compound heterozygous mutation in the alpha subunit of the hexosaminidase A gene (HEXA; 606869) on chromosome 15q23. […] Tay-Sachs disease is an autosomal recessive, progressive neurodegenerative disorder which, in the classic infantile form, is usually fatal by age 2 or 3 years. […] The gene responsible for the juvenile form has been shown by molecular analysis of the HEXA gene to be allelic to that responsible for the classic infantile form of Tay-Sachs disease (Paw et al., 1990). […] Myerowitz and Costigan (1988) demonstrated that the most frequent DNA lesion in Tay-Sachs disease in Ashkenazi Jews is a 4-bp insertion in exon 11 of the HEXA gene (606869.0001). […] The defect is a partial deficiency of hexosaminidase A. […] The relatively high frequency of the atypical adult disorder(s) in Ashkenazim is the result of the high frequency of the TSD allele to create genetic compounds.

• #43 Tay-Sachs Disease: Symptoms, Causes, Treatment, Prevention

  https://www.webmd.com/parenting/baby/what-is-tay-sachs-disease

  Tay-Sachs disease is a rare, fatal disorder most commonly diagnosed in babies around 6 months of age. […] Theres no cure for the disease, but scientists have a good idea of what causes it, how it worsens, and how to use genetic testing to screen for it early in pregnancy. […] Defects in a gene called HEXA cause Tay-Sachs. […] Most people have two healthy versions of this HEXA gene, which gives instructions to your body to make an enzyme (a type of protein) known as Hex-A. […] But babies born with Tay-Sachs disease got a changed copy of the gene from both parents, so they dont make any Hex-A protein. This is what makes them so sick. […] Over time, GM2 ganglioside builds up in their nervous system and starts to cause damage. […] The disease is very rare. It affects only about 1 in every 112,000 live births.

• #44 Tay-Sachs Disease: Causes, Symptoms, and Treatment

  https://www.medicoverhospitals.in/diseases/taysachs-disease/

  Tay-Sachs disease is a lysosomal storage disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). This enzyme deficiency leads to the accumulation of a fatty substance called GM2 ganglioside in neurons, ultimately causing neuronal damage and death. […] Tay-Sachs disease is inherited in an autosomal recessive manner, meaning that an individual must inherit two defective copies of the HEXA gene, one from each parent, to manifest the disease. The HEXA gene, located on chromosome 15, encodes the Hex-A enzyme. Mutations in the HEXA gene disrupt the normal function of Hex-A, leading to the toxic buildup of GM2 ganglioside. […] Carrier screening and genetic testing are crucial for the prevention and early diagnosis of Tay-Sachs disease. Individuals of Ashkenazi Jewish descent, French-Canadian, and Cajun populations have a higher carrier frequency for Tay-Sachs disease, making screening particularly important in these groups. […] Genetic testing confirms the diagnosis by identifying mutations in the HEXA gene. This is particularly important for carrier screening and prenatal diagnosis.

• #45 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #46 Tay-Sachs disease: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/001417.htm

  Tay-Sachs disease occurs when the body lacks hexosaminidase A. This is a protein that helps break down a group of chemicals found in nerve tissue called gangliosides. Without this protein, gangliosides, particularly ganglioside GM2, build up in cells, often nerve cells in the brain. […] Tay-Sachs disease is caused by a variant gene on chromosome 15. When both parents carry the variant Tay-Sachs gene, a child has a 25% chance of developing the disease. The child must receive two copies of the variant gene, one from each parent, in order to become sick. If only one parent passes the variant gene to the child, the child is called a carrier. They will not be sick, but may pass the disease to their own children. […] Anyone can be a carrier of the Tay-Sachs gene. But, the disease is most common among people with Ashkenazi Jewish ancestry, where 1 in every 27 people carries the Tay-Sachs gene.

• #47 Tay-Sachs Disease | SpringerLink

  https://link.springer.com/10.1007/978-1-4614-6430-3_225-2

  Tay-Sachs disease is a hereditary neurodegenerative disorder resulting from excess storage of GM2 ganglioside within the lysosomes of cells, caused by deficiency of hexosaminidase A. […] The incidence of the disease is estimated to be 1 in 3,600 in Ashkenazi Jews (AJ) with carrier frequency of 1 in 30 and 1 in 360,000 in other population with carrier frequency of 1 in 300. […] Tay-Sachs disease is the most frequently occurring sphingolipidoses.

• #48 Tay-Sachs Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/14348-tay-sachs-disease

  A child is more at risk of developing Tay-Sachs disease if both of their biological parents carry the genetic variant. Anyone can be a carrier of the genetic variant. The condition is more common among people of French-Canadian, Eastern European or Ashkenazi Jewish descent, where approximately 1 in 30 people carry the genetic variant.

• #49 Tay-Sachs Disease | The Children’s Hospital at Montefiore

  https://www.cham.org/health-library/article?id=hw182975

  Tay-Sachs can occur when parents pass on a changed gene to their child. […] The juvenile and late-onset forms of Tay-Sachs are also caused by a changed gene from both parents. […] The changed gene that causes Tay-Sachs disease is more commonly found in people of Ashkenazi Jewish descent. About 3 out of 100 people in this population are carriers of the disease. People of French-Canadian descent or Cajun descent are also more likely to carry the changed gene. […] Carriers of the Tay-Sachs gene changes can pass the changed gene to their children even though the carriers don’t have the disease. If both you and your partner are carriers, there is a 1-out-of-4 chance (25%) that any child you have will have Tay-Sachs disease.

• #50 Patient Basics: Tay-Sachs Disease | 2 Minute Medicine

  https://www.2minutemedicine.com/patient-basics-tay-sachs-disease/

  Tay-Sachs disease is an inherited disease caused by an abnormal gene. People with this abnormal gene do not have an important enzyme called hexosaminidase A (HEXA) that helps to break down a fatty material called ganglioside GM2. This material builds up in the brain, and eventually damages nerve cells and causes neurological problems. […] Tay-Sachs disease is an autosomal recessive inherited disorder, meaning a child inherits one copy of the abnormal gene from each parent. The parents do not actually have the disease, but carry the Tay-Sachs gene and pass it on to the baby. If both parents have the abnormal Tay-Sachs gene, there is a one-in-four chance that their child will inherit the gene from both of them and have Tay-Sachs disease. […] Tay-Sachs disease is most common in Ashkenazi Jews. About one in 30 people with this ancestry carry a copy of the gene. Some non-Jewish groups also have a higher chance of carrying the disease. They include people whose ancestors were French-Canadian, from the Louisiana bayou, or from Amish populations in Pennsylvania.

• #51 Tay-Sachs Disease | The Children’s Hospital at Montefiore

  https://www.cham.org/health-library/article?id=hw182975

  Tay-Sachs can occur when parents pass on a changed gene to their child. […] The juvenile and late-onset forms of Tay-Sachs are also caused by a changed gene from both parents. […] The changed gene that causes Tay-Sachs disease is more commonly found in people of Ashkenazi Jewish descent. About 3 out of 100 people in this population are carriers of the disease. People of French-Canadian descent or Cajun descent are also more likely to carry the changed gene. […] Carriers of the Tay-Sachs gene changes can pass the changed gene to their children even though the carriers don’t have the disease. If both you and your partner are carriers, there is a 1-out-of-4 chance (25%) that any child you have will have Tay-Sachs disease.

• #52 Tay-Sachs disease – ThinkGenetic Foundation

  https://thinkgenetic.org/diseases/tay-sachs-disease/

  As of 2017, being a carrier for Tay-Sachs disease is more common in individuals of Ashkenazi Jewish ancestry, as well as in some French-Canadian communities of Quebec, the Old Order Amish community in Pennsylvania, and the Cajun population of Louisiana; however, the incidence of Tay-Sachs disease in many communities has decreased due to implementation of population-based screening programs. […] Tay-Sachs disease is caused because people have a change or alteration (mutation) in both their HEXA genes. This gene produces an enzyme that is needed to break down GM2 ganglioside. Tay-Sachs disease is inherited in an autosomal recessive manner, which means that a child inherits one altered HEXA gene from each parent. […] Tay-Sachs disease is caused by gene changes in the HEXA gene. […] Tay-Sachs disease is caused by a change in a gene called HEXA. The HEXA gene produces an enzyme known as beta hexosaminidase A, which is required to break down fatty material called GM2 ganglioside within lysosomes.

• #53 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #54 Tay-Sachs Disease | SpringerLink

  https://link.springer.com/10.1007/978-1-4614-6430-3_225-2

  Tay-Sachs disease is a hereditary neurodegenerative disorder resulting from excess storage of GM2 ganglioside within the lysosomes of cells, caused by deficiency of hexosaminidase A. […] The incidence of the disease is estimated to be 1 in 3,600 in Ashkenazi Jews (AJ) with carrier frequency of 1 in 30 and 1 in 360,000 in other population with carrier frequency of 1 in 300. […] Tay-Sachs disease is the most frequently occurring sphingolipidoses.

• #55 Tay-Sachs disease – ThinkGenetic Foundation

  https://thinkgenetic.org/diseases/tay-sachs-disease/

  As of 2017, being a carrier for Tay-Sachs disease is more common in individuals of Ashkenazi Jewish ancestry, as well as in some French-Canadian communities of Quebec, the Old Order Amish community in Pennsylvania, and the Cajun population of Louisiana; however, the incidence of Tay-Sachs disease in many communities has decreased due to implementation of population-based screening programs. […] Tay-Sachs disease is caused because people have a change or alteration (mutation) in both their HEXA genes. This gene produces an enzyme that is needed to break down GM2 ganglioside. Tay-Sachs disease is inherited in an autosomal recessive manner, which means that a child inherits one altered HEXA gene from each parent. […] Tay-Sachs disease is caused by gene changes in the HEXA gene. […] Tay-Sachs disease is caused by a change in a gene called HEXA. The HEXA gene produces an enzyme known as beta hexosaminidase A, which is required to break down fatty material called GM2 ganglioside within lysosomes.

• #56 Tay-Sachs Disease – Blu Genes Foundation

  https://blugenes.org/tay-sachs-disease/

  The availability of carrier screening and prenatal testing has decreased the incidence of Tay-Sachs disease in populations known to have a high risk for the disease. […] There is currently no cure for Tay-Sachs disease. In the more common infantile- and the juvenile-onset forms of the disease, treatment is currently limited to management of symptoms and support. […] One of the most promising avenues of research is gene therapy. Gene therapy is complex, but the idea is to find a way of packaging a correct version of the defective gene (HEXA in the case of Tay-Sachs disease) so that it can be delivered into the affected cells (nerve cells in the central nervous system in the case of Tay-Sachs disease), much like a patch in the case of faulty software.

• #57 Tay-Sachs Disease: Causes and Symptoms | Doctor

  https://patient.info/doctor/tay-sachs-disease.htm

  Tay-Sachs disease (and its variants) are caused by absence or defects of the alpha subunit of hexosaminidase A. This leads to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina. This causes progressive neurodegeneration and developmental delay. […] Tay-Sachs disease is an autosomal recessive inherited disorder. […] Screening for carriers in affected populations, especially in family members of affected patients. This should be offered with preconception counselling.

• #58 Tay-Sachs Disease: Causes, Symptoms, and Treatment

  https://www.medicoverhospitals.in/diseases/taysachs-disease/

  Tay-Sachs disease is a lysosomal storage disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). This enzyme deficiency leads to the accumulation of a fatty substance called GM2 ganglioside in neurons, ultimately causing neuronal damage and death. […] Tay-Sachs disease is inherited in an autosomal recessive manner, meaning that an individual must inherit two defective copies of the HEXA gene, one from each parent, to manifest the disease. The HEXA gene, located on chromosome 15, encodes the Hex-A enzyme. Mutations in the HEXA gene disrupt the normal function of Hex-A, leading to the toxic buildup of GM2 ganglioside. […] Carrier screening and genetic testing are crucial for the prevention and early diagnosis of Tay-Sachs disease. Individuals of Ashkenazi Jewish descent, French-Canadian, and Cajun populations have a higher carrier frequency for Tay-Sachs disease, making screening particularly important in these groups. […] Genetic testing confirms the diagnosis by identifying mutations in the HEXA gene. This is particularly important for carrier screening and prenatal diagnosis.

• #59 Tay-Sachs Disease | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/health-topics/tay-sachs-disease

  Tay-Sachs disease is a rare, inherited disease. It is a type of lipid metabolism disorder. It causes too much of a fatty substance to build up in the brain. This buildup destroys nerve cells, causing mental and physical problems. […] The cause is a gene mutation which is most common in Eastern European Ashkenazi Jews. To get the disease, both parents must have the gene. If they do, there is a 25% chance of the child having the disease. […] A blood test and prenatal tests can check for the gene or the disease.

• #60 Biochemistry and Genetics of Tay-Sachs Disease | Canadian Journal of Neurological Sciences | Cambridge Core

  https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/biochemistry-and-genetics-of-taysachs-disease/87579DAC3E430C57857E7294D168EE3C

  Tay-Sachs disease is one of the few neurodegenerative diseases of known cause. It results from mutations of the HEXA gene encoding the a subunit of -hexosaminidase, producing a destructive ganglioside accumulation in lysosomes, principally in neurons. […] More recently, detailed knowledge of the gene structure has allowed the determination of specific mutations causing Tay-Sachs disease. The high incidence of the disease in Ashkenazi Jews is attributed predominantly to three mutations present in high frequency, while in non-Jews some two dozen mutations have been identified thus far. […] The cataloguing of mutations has important implications for carrier screening and prenatal diagnosis for Tay-Sachs disease.

• #61 Tay-Sachs disease – Genes and Disease – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK22250/

  Tay-Sachs is an autosomal recessive disease caused by mutations in both alleles of a gene (HEXA) on chromosome 15. HEXA codes for the alpha subunit of the enzyme -hexosaminidase A. This enzyme is found in lysosomes, organelles that break down large molecules for recycling by the cell. Normally, -hexosaminidase A helps to degrade a lipid called GM2 ganglioside, but in Tay-Sachs individuals, the enzyme is absent or present only in very reduced amounts, allowing excessive accumulation of the GM2 ganglioside in neurons. […] The progressive neurodegeneration seen in the varied forms of Tay-Sachs depends upon the speed and degree of GM2 ganglioside accumulation, which in turn is dependent upon the level of functional -hexosaminidase A present in the body.

• #62 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #63 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #64 Tay-Sachs Disease | Enhanced Dental CPD Online

  https://www.dentaljuce.com/shorts-tay-sachs-disease

  TaySachs is caused by mutations in the HEXA gene on chromosome 15, which leads to a deficiency in the enzyme hexosaminidase A. This enzyme deficiency results in the accumulation of GM2 gangliosides in neurons, causing cellular toxicity. […] TaySachs disease is caused by insufficient activity of the enzyme hexosaminidase A, which is essential for breaking down sphingolipids in lysosomes. The lack of this enzyme leads to the accumulation of GM2 gangliosides, primarily in neurons, causing cellular dysfunction and death. […] The disease is inherited in an autosomal recessive pattern, meaning both parents must be carriers. The most prevalent mutation in the Ashkenazi Jewish population is a four base pair insertion in exon 11 of the HEXA gene. […] TaySachs disease follows an autosomal recessive inheritance pattern. […] TaySachs disease is caused by a deficiency in the enzyme hexosaminidase A, leading to the accumulation of GM2 gangliosides in nerve cells.

• #65 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #66 Tay-Sachs disease – Genes and Disease – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK22250/

  Tay-Sachs is an autosomal recessive disease caused by mutations in both alleles of a gene (HEXA) on chromosome 15. HEXA codes for the alpha subunit of the enzyme -hexosaminidase A. This enzyme is found in lysosomes, organelles that break down large molecules for recycling by the cell. Normally, -hexosaminidase A helps to degrade a lipid called GM2 ganglioside, but in Tay-Sachs individuals, the enzyme is absent or present only in very reduced amounts, allowing excessive accumulation of the GM2 ganglioside in neurons. […] The progressive neurodegeneration seen in the varied forms of Tay-Sachs depends upon the speed and degree of GM2 ganglioside accumulation, which in turn is dependent upon the level of functional -hexosaminidase A present in the body.

• #67 Tay-Sachs disease: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/tay-sachs-disease/

  Tay-Sachs disease is a rare, inherited disorder that is characterized by neurological problems caused by the death of nerve cells (neurons) in the brain and spinal cord (central nervous system). […] Variants in the HEXA gene cause Tay-Sachs disease. The HEXA gene provides instructions for making one part (the alpha subunit) of an enzyme called beta-hexosaminidase A. […] HEXA gene variants affect the ability of the beta-hexosaminidase A enzyme to break down GM2 ganglioside. As a result, GM2 ganglioside accumulates to toxic levels, particularly in neurons in the central nervous system. Damage caused by the buildup of GM2 ganglioside leads to the dysfunction and eventual death of these neurons, which causes the signs and symptoms of Tay-Sachs disease. […] HEXA gene variants that eliminate or severely reduce beta-hexosaminidase A enzyme function likely lead to the infantile form of Tay-Sachs disease, and variants that allow some residual enzyme activity tend to cause the juvenile or late-onset form of the condition. […] Because Tay-Sachs disease impairs the function of a lysosomal enzyme and involves the buildup of GM2 ganglioside, this condition is sometimes referred to as a lysosomal storage disorder or a GM2-gangliosidosis.

• #68 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #69 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #70 Tay-Sachs disease – Genes and Disease – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK22250/

  Tay-Sachs is an autosomal recessive disease caused by mutations in both alleles of a gene (HEXA) on chromosome 15. HEXA codes for the alpha subunit of the enzyme -hexosaminidase A. This enzyme is found in lysosomes, organelles that break down large molecules for recycling by the cell. Normally, -hexosaminidase A helps to degrade a lipid called GM2 ganglioside, but in Tay-Sachs individuals, the enzyme is absent or present only in very reduced amounts, allowing excessive accumulation of the GM2 ganglioside in neurons. […] The progressive neurodegeneration seen in the varied forms of Tay-Sachs depends upon the speed and degree of GM2 ganglioside accumulation, which in turn is dependent upon the level of functional -hexosaminidase A present in the body.

• #71 Tay-Sachs Disease – Blu Genes Foundation

  https://blugenes.org/tay-sachs-disease/

  The availability of carrier screening and prenatal testing has decreased the incidence of Tay-Sachs disease in populations known to have a high risk for the disease. […] There is currently no cure for Tay-Sachs disease. In the more common infantile- and the juvenile-onset forms of the disease, treatment is currently limited to management of symptoms and support. […] One of the most promising avenues of research is gene therapy. Gene therapy is complex, but the idea is to find a way of packaging a correct version of the defective gene (HEXA in the case of Tay-Sachs disease) so that it can be delivered into the affected cells (nerve cells in the central nervous system in the case of Tay-Sachs disease), much like a patch in the case of faulty software.

• #72 Gene Transfer Strategy Used to Treat Tay – Sachs Disease (2005), by Sabata Martino’s Research Group | Embryo Project Encyclopedia

  https://embryo.asu.edu/pages/gene-transfer-strategy-used-treat-tay-sachs-disease-2005-sabata-martinos-research-group

  Tay-Sachs disease is a fatal degenerative disorder that occurs in infants and causes rapid motor and mental impairment, leading to death at the ages of three to five. […] In humans with Tay-Sachs, the gene coding for the enzyme HEXA is missing. Without that gene, the body cannot produce the enzyme hexosaminidase subunit alpha. […] Humans with Tay-Sachs do not have that enzyme to break down GM2 gangliosides. As a result, GM2 gangliosides build up in cells to toxic levels and destroy those cells, which are mainly located in the central nervous system. That damage causes the symptoms of Tay-Sachs. […] The infected Tay-Sachs mice in the experiment confirmed the researchers’ hypothesis that the use of gene therapy via HSV-1 viral vector into the internal capsule would decrease GM2 gangliosides build up and restore Hexa, slowing down Tay-Sachs symptoms.

• #73 Tay-Sachs Disease | Condition | Unity Screen

  https://www.unityscreen.com/conditions/tay-sachs-disease

  Tay-Sachs disease is a rare genetic disorder that causes progressive neurological decline due to the toxic buildup of lipids in brain cells. […] Tay-Sachs disease is an inherited condition that affects the nervous system. It occurs when the body is unable to break down a specific type of fat, causing it to build up in the brain and nerve cells. […] Tay-Sachs disease is an autosomal recessive condition. This means that a person must inherit two non-functional HEXA genes, one from each of their parents, to be affected with Tay-Sachs disease. […] Currently, there is no cure for Tay-Sachs disease. However, clinical trials are ongoing for gene and enzyme replacement therapies to slow progression of the disease. […] Treatment is supportive and mainly focuses on managing the symptoms of Tay-Sachs disease with medications, therapies and nutrition support.

• #74 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #75 Frontiers | Therapeutic Strategies For Tay-Sachs Disease

  https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.906647/full

  Tay-Sachs disease (TSD) is an autosomal recessive disease that features progressive neurodegenerative presentations. It affects one in 100,000 live births. […] GM2-gangliosidoses are a group of three lysosomal storage disorders (LSDs) that result from a deficiency in one of the lysosomal enzymes β-hexosaminidases (Hex A, B, or S) or the GM2 activator protein (GM2A). This deficiency prevents the degradation of GM2 ganglioside (GM2) into GM3 ganglioside and causes a cytotoxic accumulation of GM2. […] TSD is a congenital, autosomal recessive, neurodegenerative disease caused by mutations in the hexosaminidase A (HEXA) gene. It has an incidence rate of about one in 100,000 live births with a carrier frequency of about one in 250. […] There are over 130 known HEXA mutations that lead to alterations in transcription, translation, protein folding and dimerization, as well as catalytic function. […] Various mutations in HexA result in a wide gradient of reduced enzymatic function and thus a wide spectrum in clinical severity of TSD. However, only 10–15% of residual enzymatic activity is necessary to avoid GM2 gangliosidosis.

• #76 Tay-Sachs Disease | Condition | Unity Screen

  https://www.unityscreen.com/conditions/tay-sachs-disease

  Tay-Sachs disease is a rare genetic disorder that causes progressive neurological decline due to the toxic buildup of lipids in brain cells. […] Tay-Sachs disease is an inherited condition that affects the nervous system. It occurs when the body is unable to break down a specific type of fat, causing it to build up in the brain and nerve cells. […] Tay-Sachs disease is an autosomal recessive condition. This means that a person must inherit two non-functional HEXA genes, one from each of their parents, to be affected with Tay-Sachs disease. […] Currently, there is no cure for Tay-Sachs disease. However, clinical trials are ongoing for gene and enzyme replacement therapies to slow progression of the disease. […] Treatment is supportive and mainly focuses on managing the symptoms of Tay-Sachs disease with medications, therapies and nutrition support.

• #77 Tay-Sachs disease | Altru Health System

  https://www.altru.org/health-library/conditions/tay-sachs-disease

  Tay-Sachs disease is a genetic disorder that is passed from parents to their children. It occurs when a child inherits a flaw (mutation) in the HEXA gene from both parents. […] The genetic change that causes Tay-Sachs disease results in a deficiency of the enzyme beta-hexosaminidase A. This enzyme is required to break down the fatty substance GM2 ganglioside. The buildup of fatty substances damages nerve cells in the brain and spinal cord. Severity and age of onset of the disease relates to how much enzyme is still produced.

• #78 Tay-Sachs disease | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/tay-sachs-disease?content_id=CON-20378183

  Tay-Sachs disease is a rare genetic disorder passed from parents to child. It’s caused by the absence of an enzyme that helps break down fatty substances. These fatty substances, called gangliosides, build up to toxic levels in the brain and spinal cord and affect the function of the nerve cells. […] Tay-Sachs disease is a genetic disorder that is passed from parents to their children. It occurs when a child inherits a flaw (mutation) in the HEXA gene from both parents. […] The genetic change that causes Tay-Sachs disease results in a deficiency of the enzyme beta-hexosaminidase A. This enzyme is required to break down the fatty substance GM2 ganglioside. The buildup of fatty substances damages nerve cells in the brain and spinal cord. Severity and age of onset of the disease relates to how much enzyme is still produced.

• #79 Tay-Sachs disease: Causes, symptoms, diagnosis, and more

  https://www.medicalnewstoday.com/articles/tay-sachs-disease

  Tay-Sachs disease is an inherited, life threatening condition where nerve cells in the brain and spinal cord degenerate and die. This leads to progressive neurological dysfunction. […] A deficiency in the enzyme that breaks down a fatty substance in nerve cells, HexA, may cause Tay-Sachs disease. This deficiency stems from inheriting a mutated form of the gene coding for the specific enzyme that a person inherits from each parent. […] A deficiency of the enzyme beta-hexosaminidase (HexA) causes Tay-Sachs disease. […] When insufficient HexA is available, GM2 ganglioside builds up atypically in cells in the brain and spinal cord. This leads to cell degeneration and death. […] The condition stems from a gene mutation on chromosome 15 that codes for HexA production. […] People inherit this condition in an autosomal recessive pattern. […] The condition results from a deficiency in HexA, an enzyme that prevents the accumulation of a fatty substance in the nerve cells. This happens when someone inherits a pair of mutated genes that code for the bodys HexA synthesis.

• #80 Tay-Sachs Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564432/

  Tay-Sachs disease belongs to a group of autosomal recessively inherited lysosomal storage disorders called GM2 gangliosidoses. GM2 gangliosides accumulate inside lysosomes, primarily affecting the nervous system and resulting in neuronal dysfunction and neurodegeneration. The other GM2 gangliosidoses are Sandhoff disease and the AB variant. […] Tay-Sachs disease is an autosomal recessive disorder caused by a mutation in HEXA, which encodes the enzymes beta-hexosaminidase A. HEXA is located at 15q23. More than 130 mutations have been identified, including single gene deletions, substitution, insertion splicing alteration, duplication, and complex gene rearrangements. Very rare founder variants of Tay-Sachs disease have been identified recently in India.

• #81 Tay-Sachs disease | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/tay-sachs-disease

  Tay-Sachs disease (TSD) is a genetic condition that affects the nervous system. […] TSD is caused by an alteration in the HEXA gene on chromosome 15. […] In children with TSD, the gene that tells the neurones to produce HexA is altered and stops the neurones from producing the enzyme. […] Tay-Sachs disease is most commonly observed in individuals of Jewish and French-Canadian descent, but can also occur in people from other backgrounds. […] TSD follows an autosomal recessive inheritance pattern. […] To develop TSD, a child must inherit an altered gene copy from both parents. […] If a male and a female, each carrying an altered HEXA gene, conceive a child, there is a one-in-four chance that the child will have TSD. […] If only one parent has the altered gene, none of their children will develop the condition, but each child has a 50 per cent chance of being a genetic carrier of TSD.

• #82 Tay–Sachs disease – Wikipedia

  https://en.wikipedia.org/wiki/Tay%E2%80%93Sachs_disease

  TaySachs disease is caused by a genetic mutation in the HEXA gene on chromosome 15, which codes a subunit of the hexosaminidase enzyme known as hexosaminidase A. […] It is inherited in an autosomal recessive manner. […] The mutation disrupts the activity of the enzyme, which results in the build-up of the molecule GM2 ganglioside within cells, leading to toxicity. […] TaySachs disease is an autosomal recessive genetic disorder, meaning that when both parents are carriers, there is a 25% risk of giving birth to an affected child with each pregnancy. […] TaySachs results from mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of beta-N-acetylhexosaminidase A, a lysosomal enzyme. […] Classic infantile TaySachs disease results when a child has inherited mutations from both parents that completely stop the biodegradation of gangliosides.

• #83 Tay-Sachs Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/14348-tay-sachs-disease

  A child is more at risk of developing Tay-Sachs disease if both of their biological parents carry the genetic variant. Anyone can be a carrier of the genetic variant. The condition is more common among people of French-Canadian, Eastern European or Ashkenazi Jewish descent, where approximately 1 in 30 people carry the genetic variant.

• #84 About Tay-Sachs Disease

  https://www.genome.gov/Genetic-Disorders/Tay-Sachs-Disease

  Tay-Sachs is caused by the absence of a vital enzyme called hexosaminidase-A (Hex-A). Without Hex-A, a fatty substance, or lipid, called GM2 ganglioside accumulates abnormally in cells, especially in the nerve cells of the brain. This ongoing accumulation causes progressive damage to the cells. […] Tay-Sachs disease results from defects in a gene on chromosome 15 that codes for production of the enzyme Hex-A. […] Carriers of Tay-Sachs – people who have one copy of the inactive gene along with one copy of the active gene – are healthy. […] If both parents are carriers and their child inherits the defective Hex-A gene from each of them, the child will have Tay-Sachs disease. […] While anyone can be a carrier of Tay-Sachs, the incidence of the disease is significantly higher among people of eastern European (Ashkenazi) Jewish descent. Approximately one in every 27 Jews in the United States is a carrier of the Tay-Sachs disease gene. […] For the general population, about one in 250 people are carriers.

• #85 Biochemistry and Genetics of Tay-Sachs Disease | Canadian Journal of Neurological Sciences | Cambridge Core

  https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/biochemistry-and-genetics-of-taysachs-disease/87579DAC3E430C57857E7294D168EE3C

  Tay-Sachs disease is one of the few neurodegenerative diseases of known cause. It results from mutations of the HEXA gene encoding the a subunit of -hexosaminidase, producing a destructive ganglioside accumulation in lysosomes, principally in neurons. […] More recently, detailed knowledge of the gene structure has allowed the determination of specific mutations causing Tay-Sachs disease. The high incidence of the disease in Ashkenazi Jews is attributed predominantly to three mutations present in high frequency, while in non-Jews some two dozen mutations have been identified thus far. […] The cataloguing of mutations has important implications for carrier screening and prenatal diagnosis for Tay-Sachs disease.

• #86 Tay-Sachs Disease: Causes, Symptoms, and Treatment

  https://www.medicoverhospitals.in/diseases/taysachs-disease/

  Tay-Sachs disease is a lysosomal storage disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). This enzyme deficiency leads to the accumulation of a fatty substance called GM2 ganglioside in neurons, ultimately causing neuronal damage and death. […] Tay-Sachs disease is inherited in an autosomal recessive manner, meaning that an individual must inherit two defective copies of the HEXA gene, one from each parent, to manifest the disease. The HEXA gene, located on chromosome 15, encodes the Hex-A enzyme. Mutations in the HEXA gene disrupt the normal function of Hex-A, leading to the toxic buildup of GM2 ganglioside. […] Carrier screening and genetic testing are crucial for the prevention and early diagnosis of Tay-Sachs disease. Individuals of Ashkenazi Jewish descent, French-Canadian, and Cajun populations have a higher carrier frequency for Tay-Sachs disease, making screening particularly important in these groups. […] Genetic testing confirms the diagnosis by identifying mutations in the HEXA gene. This is particularly important for carrier screening and prenatal diagnosis.

Zobacz więcej